Author Topic: Association of Rituxan treatment w/disability progression in SPMS  (Read 113 times)

0 Members and 2 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
From JAMA Neurology (January 7, 2019), a study entitled "Association of rituximab treatment with disability progression in patients with secondary progressive multiple sclerosis":


https://jamanetwork.com/journals/jamaneurology/fullarticle/2719699?guestAccessKey=6de7dba2-35ee-4cd5-b1c2-3a62a3f9bef8&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaneurology&utm_content=etoc&utm_term=031119
« Last Edit: March 14, 2019, 11:15:52 am by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
169 Views
Last post March 23, 2016, 03:35:11 pm
by agate
0 Replies
141 Views
Last post September 18, 2016, 10:53:12 am
by agate
0 Replies
45 Views
Last post July 27, 2020, 02:08:41 pm
by agate
0 Replies
45 Views
Last post November 11, 2020, 09:26:40 pm
by agate
0 Replies
28 Views
Last post March 21, 2022, 09:21:08 pm
by agate